Search tips
Search criteria 


Logo of taosLink to Publisher's site
Trans Am Ophthalmol Soc. 1998; 96: 881–923.
PMCID: PMC1298416

Acquired mitochondrial impairment as a cause of optic nerve disease.


BACKGROUND: Blindness from an optic neuropathy recently occurred as an epidemic affecting 50,000 patients in Cuba (CEON) and had clinical features reminiscent of both tobacco-alcohol amblyopia (TAA) and Leber's hereditary optic neuropathy (Leber's; LHON). Selective damage to the papillomacular bundle was characteristic, and many patients also developed a peripheral neuropathy. Identified risk factors included vitamin deficiencies as well as exposure to methanol and cyanide. In all 3 syndromes, there is evidence that singular or combined insults to mitochondrial oxidative phosphorylation are associated with a clinically characteristic optic neuropathy. PURPOSE: First, to test the hypothesis that a common pathophysiologic mechanism involving impairment of mitochondria function and, consequently, axonal transport underlies both genetic optic nerve diseases such as Leber's and acquired toxic and nutritional deficiency optic neuropathies. According to this hypothesis, ATP depletion below a certain threshold leads to a blockage of orthograde axonal transport of mitochondria, which, in turn, leads to total ATP depletion and subsequent cell death. Second, to address several related questions, including (1) How does impaired energy production lead to optic neuropathy, particularly since it seems to relatively spare other metabolically active tissues, such as liver and heart? (2) Within the nervous system, why is the optic nerve, and most particularly the papillomacular bundle, so highly sensitive? Although there have been previous publications on the clinical features of the Cuban epidemic of blindness, the present hypothesis and the subsequent questions have not been previously addressed. METHODS: Patients in Cuba with epidemic optic neuropathy were personally evaluated through a comprehensive neuro-ophthalmologic examination. In addition, serum, lymphocytes for DNA analysis, cerebrospinal fluid (CSF), sural nerves, and eyes with attached optic nerves were obtained from Cuban patients, as well as from Leber's patients, for study. Finally, we developed an animal model to match the low serum folic acid and high serum formate levels found in the CEON patients, by administering to rats low doses of methanol after several months of a folic acid-deficient diet. Optic nerves and other tissues obtained from these rats were analyzed and compared with those from the Cuban patients. RESULTS: Patients from the Cuban epidemic of optic neuropathy with clinical evidence of a selective loss of the papillomacular bundle did much better once their nutritional status was corrected and exposure to toxins ceased. Patients with CEON often demonstrated low levels of folic acid and high levels of formate in their blood. Histopathologic studies demonstrated losses of the longest fibers (in the sural nerve) and those of smallest caliber (papillomacular bundle) in the optic nerve, with intra-axonal accumulations just anterior to the lamina cribrosa. Our animal model duplicated the serologic changes (low folic acid, high formate) as well as these histopathologic changes. Furthermore, ultrastructural examination of rat tissues demonstrated mitochondrial changes that further matched those seen on ultrastructural examination of tissues from patients with Leber's. CONCLUSION: Mitochondria can be impaired either genetically (as in Leber's) or through acquired insults (such as nutritional or toxic factors). Either may challenge energy production in all cells of the body. While this challenge may be met through certain compensatory mechanisms (such as in the size, shape, or number of the mitochondria), there exists in neurons a threshold which, once passed, leads to catastrophic changes. This threshold may be that point at which mitochondrial derangement leads to such ATP depletion that axonal transport is compromised, and decreased mitochondrial transport results in even further ATP depletion. Neurons are singularly dependent on the axonal transport of mitochondria. (

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (6.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Sadun AA, Martone JF, Reyes L, Du Bois L, Roman GC, Caballero B. Optic and peripheral neuropathy in Cuba. JAMA. 1994 Mar 2;271(9):663–664. [PubMed]
  • Lincoff NS, Odel JG, Hirano M. 'Outbreak' of optic and peripheral neuropathy in Cuba? JAMA. 1993 Jul 28;270(4):511–518. [PubMed]
  • Sadun AA, Martone JF, Muci-Mendoza R, Reyes L, DuBois L, Silva JC, Roman G, Caballero B. Epidemic optic neuropathy in Cuba. Eye findings. Arch Ophthalmol. 1994 May;112(5):691–699. [PubMed]
  • Nikoskelainen E, Hoyt WF, Nummelin K, Schatz H. Fundus findings in Leber's hereditary optic neuroretinopathy. III. Fluorescein angiographic studies. Arch Ophthalmol. 1984 Jul;102(7):981–989. [PubMed]
  • Newman NJ, Torroni A, Brown MD, Lott MT, Fernandez MM, Wallace DC. Epidemic neuropathy in Cuba not associated with mitochondrial DNA mutations found in Leber's hereditary optic neuropathy patients. Cuba Neuropathy Field Investigation Team. Am J Ophthalmol. 1994 Aug 15;118(2):158–168. [PubMed]
  • Johns DR. The molecular genetics of Leber's hereditary optic neuropathy. Arch Ophthalmol. 1990 Oct;108(10):1405–1407. [PubMed]
  • Newman NJ, Wallace DC. Mitochondria and Leber's hereditary optic neuropathy. Am J Ophthalmol. 1990 Jun 15;109(6):726–730. [PubMed]
  • Johns DR, Sadun AA. Cuban epidemic optic neuropathy. Mitochondrial DNA analysis. J Neuroophthalmol. 1994 Sep;14(3):130–134. [PubMed]
  • McMartin KE, Ambre JJ, Tephly TR. Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis. Am J Med. 1980 Mar;68(3):414–418. [PubMed]
  • Sejersted OM, Jacobsen D, Ovrebø S, Jansen H. Formate concentrations in plasma from patients poisoned with methanol. Acta Med Scand. 1983;213(2):105–110. [PubMed]
  • BENTON CD, Jr, CALHOUN FP., Jr The ocular effects of methyl alcohol poisoning: report of a catastrophe involving three hundred and twenty persons. Trans Am Acad Ophthalmol Otolaryngol. 1952 Nov-Dec;56(6):875–885. [PubMed]
  • Eells JT. Methanol-induced visual toxicity in the rat. J Pharmacol Exp Ther. 1991 Apr;257(1):56–63. [PubMed]
  • Jacobsen D, McMartin KE. Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986 Sep-Oct;1(5):309–334. [PubMed]
  • Dethlefs R, Naraqi S. Ocular manifestations and complications of acute methyl alcohol intoxication. Med J Aust. 1978 Nov 4;2(10):483–485. [PubMed]
  • Nicholls P. Formate as an inhibitor of cytochrome c oxidase. Biochem Biophys Res Commun. 1975 Nov 17;67(2):610–616. [PubMed]
  • Nicholls P. The effect of formate on cytochrome aa3 and on electron transport in the intact respiratory chain. Biochim Biophys Acta. 1976 Apr 9;430(1):13–29. [PubMed]
  • Golnik KC, Schaible ER. Folate-responsive optic neuropathy. J Neuroophthalmol. 1994 Sep;14(3):163–169. [PubMed]
  • Lee EW, Garner CD, Terzo TS. Animal model for the study of methanol toxicity: comparison of folate-reduced rat responses with published monkey data. J Toxicol Environ Health. 1994 Jan;41(1):71–82. [PubMed]
  • Jestico JV, O'Brien MD, Teoh R, Toseland PA, Wong HC. Whole blood cyanide levels in patients with tobacco amblyopia. J Neurol Neurosurg Psychiatry. 1984 Jun;47(6):573–578. [PMC free article] [PubMed]
  • Brontë-Stewart J, Pettigrew AR, Foulds WS. Toxic optic neuropathy and its experimental production. Trans Ophthalmol Soc U K. 1976 Sep;96(3):355–358. [PubMed]
  • Rizzo JF., 3rd Adenosine triphosphate deficiency: a genre of optic neuropathy. Neurology. 1995 Jan;45(1):11–16. [PubMed]
  • McMartin KE, Martin-Amat G, Makar AB, Tephly TR. Methanol poisoning. V. Role of formate metabolism in the monkey. J Pharmacol Exp Ther. 1977 Jun;201(3):564–572. [PubMed]
  • Deacon R, Perry J, Lumb M, Chanarin I. Formate metabolism in the cobalamin-inactivated rat. Br J Haematol. 1990 Mar;74(3):354–359. [PubMed]
  • Eells JT, Black KA, Tedford CE, Tephly TR. Methanol toxicity in the monkey: effects of nitrous oxide and methionine. J Pharmacol Exp Ther. 1983 Nov;227(2):349–353. [PubMed]
  • Radius RL, Anderson DR. Fast axonal transport in early experimental disc edema. Invest Ophthalmol Vis Sci. 1980 Feb;19(2):158–168. [PubMed]
  • Tso MO, Hayreh SS. Optic disc edema in raised intracranial pressure. III. A pathologic study of experimental papilledema. Arch Ophthalmol. 1977 Aug;95(8):1448–1457. [PubMed]
  • Carroll FD. Jamaican optic neuropathy in immigrants to the United States. Am J Ophthalmol. 1971 Jan;71(1 Pt 2):261–265. [PubMed]
  • Brady S. Motor-neuron diseases. Interfering with the runners. Nature. 1995 May 4;375(6526):12–13. [PubMed]
  • Collard JF, Côté F, Julien JP. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature. 1995 May 4;375(6526):61–64. [PubMed]
  • Murray TG, Burton TC, Rajani C, Lewandowski MF, Burke JM, Eells JT. Methanol poisoning. A rodent model with structural and functional evidence for retinal involvement. Arch Ophthalmol. 1991 Jul;109(7):1012–1016. [PubMed]
  • POTTS AM. The visual toxicity of methanol. VI. The clinical aspects of experimental methanol poisoning treated with base. Am J Ophthalmol. 1955 Feb;39(2 Pt 2):86–92. [PubMed]
  • Eells JT, Makar AB, Noker PE, Tephly TR. Methanol poisoning and formate oxidation in nitrous oxide-treated rats. J Pharmacol Exp Ther. 1981 Apr;217(1):57–61. [PubMed]
  • Martin-Amat G, Tephly TR, McMartin KE, Makar AB, Hayreh MS, Hayreh SS, Baumbach G, Cancilla P. Methyl alcohol poisoning. II. Development of a model for ocular toxicity in methyl alcohol poisoning using the rhesus monkey. Arch Ophthalmol. 1977 Oct;95(10):1847–1850. [PubMed]
  • Wall M, Sadun AA. Threshold Amsler grid testing. Cross-polarizing lenses enhance yield. Arch Ophthalmol. 1986 Apr;104(4):520–523. [PubMed]
  • Sadun AA, Smith LE, Kenyon KR. Paraphenylenediamine: a new method for tracing human visual pathways. J Neuropathol Exp Neurol. 1983 Mar;42(2):200–206. [PubMed]
  • Johnson BM, Sadun AA. Ultrastructural and paraphenylene studies of degeneration in the primate visual system: degenerative remnants persist for much longer than expected. J Electron Microsc Tech. 1988 Feb;8(2):179–183. [PubMed]
  • Makar AB, Tephly TR. Improved estimation of formate in body fluids and tissues. Clin Chem. 1982 Feb;28(2):385–385. [PubMed]
  • Jacobs JM, Love S. Qualitative and quantitative morphology of human sural nerve at different ages. Brain. 1985 Dec;108(Pt 4):897–924. [PubMed]
  • DeVita EG, Miao M, Sadun AA. Optic neuropathy in ethambutol-treated renal tuberculosis. J Clin Neuroophthalmol. 1987 Jun;7(2):77–86. [PubMed]
  • Torroni A, Brown MD, Lott MT, Newman NJ, Wallace DC. African, Native American, and European mitochondrial DNAs in Cubans from Pinar del Rio Province and implications for the recent epidemic neuropathy in Cuba. Cuba Neuropathy Field Investigation Team. Hum Mutat. 1995;5(4):310–317. [PubMed]
  • Sadun AA, Martone JF. Cuba: response of medical science to a crisis of optic and peripheral neuropathy. Int Ophthalmol. 1994;18(6):373–378. [PubMed]
  • Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol. 1994 Jan;112(1):37–44. [PubMed]
  • Cohen ED, Miller RF. The role of NMDA and non-NMDA excitatory amino acid receptors in the functional organization of primate retinal ganglion cells. Vis Neurosci. 1994 Mar-Apr;11(2):317–332. [PubMed]
  • Zeevalk GD, Nicklas WJ. Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther. 1991 May;257(2):870–878. [PubMed]
  • Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 1992 Feb;31(2):119–130. [PubMed]
  • Kroemer G. Mitochondrial implication in apoptosis. Towards an endosymbiont hypothesis of apoptosis evolution. Cell Death Differ. 1997 Aug;4(6):443–456. [PubMed]
  • Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997 Feb 21;275(5303):1129–1132. [PubMed]
  • Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997 Feb 21;275(5303):1132–1136. [PubMed]
  • Brady ST, Lasek RJ. Axonal transport: a cell-biological method for studying proteins that associate with the cytoskeleton. Methods Cell Biol. 1982;25(Pt B):365–398. [PubMed]
  • Borrajero I, Pérez JL, Domínguez C, Chong A, Coro RM, Rodríguez H, Gómez N, Román GC, Navarro-Román L. Epidemic neuropathy in Cuba: morphological characterization of peripheral nerve lesions in sural nerve biopsies. J Neurol Sci. 1994 Dec 1;127(1):68–76. [PubMed]
  • Ames A, 3rd, Li YY, Heher EC, Kimble CR. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci. 1992 Mar;12(3):840–853. [PubMed]
  • Johns DR, Smith KH, Miller NR, Sulewski ME, Bias WB. Identical twins who are discordant for Leber's hereditary optic neuropathy. Arch Ophthalmol. 1993 Nov;111(11):1491–1494. [PubMed]
  • Kozak SF, Inderlied CB, Hsu HY, Heller KB, Sadun AA. The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy. Diagn Microbiol Infect Dis. 1998 Feb;30(2):83–87. [PubMed]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society